{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T15:08:18Z","timestamp":1790953698794,"version":"4.1.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T00:00:00Z","timestamp":1776729600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T00:00:00Z","timestamp":1780358400000},"content-version":"vor","delay-in-days":42,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Transl Psychiatry"],"DOI":"10.1038\/s41398-026-04043-0","type":"journal-article","created":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T00:36:48Z","timestamp":1776731808000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Diagnostic performance of plasma p-tau217 levels measured with different assays for Alzheimer\u2019s disease"],"prefix":"10.1038","volume":"16","author":[{"given":"Yong","family":"He","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-8518-2644","authenticated-orcid":false,"given":"Yurou","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dequan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Che","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caixia","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9675-5322","authenticated-orcid":false,"given":"Nan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,21]]},"reference":[{"key":"4043_CR1","doi-asserted-by":"publisher","first-page":"2187","DOI":"10.1038\/s41591-023-02505-2","volume":"29","author":"WK Self","year":"2023","unstructured":"Self WK, Holtzman DM. Emerging diagnostics and therapeutics for Alzheimer disease. Nat Med. 2023;29:2187\u201399.","journal-title":"Nat Med"},{"key":"4043_CR2","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/s41572-021-00269-y","volume":"7","author":"DS Knopman","year":"2021","unstructured":"Knopman DS, Amieva H, Petersen RC, Ch\u00e9telat G, Holtzman DM, Hyman BT, et al. Alzheimer disease. Nat Rev Dis Primers. 2021;7:33.","journal-title":"Nat Rev Dis Primers"},{"key":"4043_CR3","doi-asserted-by":"publisher","first-page":"5143","DOI":"10.1002\/alz.13859","volume":"20","author":"CR Jack Jr","year":"2024","unstructured":"Jack CR Jr, Andrews JS, Beach TG, Buracchio T, Dunn B, Graf A, et al. Revised criteria for diagnosis and staging of alzheimer\u2019s disease: alzheimer\u2019s association workgroup. Alzheimers Dement. 2024;20:5143\u201369.","journal-title":"Alzheimers Dement"},{"key":"4043_CR4","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/S1474-4422(21)00361-6","volume":"21","author":"CE Teunissen","year":"2022","unstructured":"Teunissen CE, Verberk IMW, Thijssen EH, Vermunt L, Hansson O, Zetterberg H, et al. Blood-based biomarkers for Alzheimer\u2019s disease: towards clinical implementation. Lancet Neurol. 2022;21:66\u201377.","journal-title":"Lancet Neurol"},{"key":"4043_CR5","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1016\/S1474-4422(22)00168-5","volume":"21","author":"R Ossenkoppele","year":"2022","unstructured":"Ossenkoppele R, Van Der Kant R, Hansson O. Tau biomarkers in Alzheimer\u2019s disease: towards implementation in clinical practice and trials. Lancet Neurol. 2022;21:726\u201334.","journal-title":"Lancet Neurol"},{"key":"4043_CR6","doi-asserted-by":"publisher","first-page":"8216","DOI":"10.1002\/alz.14184","volume":"20","author":"MM Mielke","year":"2024","unstructured":"Mielke MM, Anderson M, Ashford JW, Jeromin A, Lin P-J, Rosen A, et al. Recommendations for clinical implementation of blood-based biomarkers for Alzheimer\u2019s disease. Alzheimers Dement. 2024;20:8216\u201324.","journal-title":"Alzheimers Dement"},{"key":"4043_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.tjpad.2025.100092","volume":"12","author":"L-M Li","year":"2025","unstructured":"Li L-M, Che P, Liu D, Wang Y, Li J, He D, et al. Diagnostic and discriminative accuracy of plasma phosphorylated tau 217 for symptomatic Alzheimer\u02bcs disease in a Chinese cohort. J Prev Alzheimer\u2019s Dis. 2025;12:100092.","journal-title":"J Prev Alzheimer\u2019s Dis"},{"key":"4043_CR8","doi-asserted-by":"publisher","first-page":"2555","DOI":"10.1038\/s41591-022-02074-w","volume":"28","author":"NJ Ashton","year":"2022","unstructured":"Ashton NJ, Janelidze S, Mattsson-Carlgren N, Binette AP, Strandberg O, Brum WS, et al. Differential roles of A\u03b242\/40, p-tau231 and p-tau217 for Alzheimer\u2019s trial selection and disease monitoring. Nat Med. 2022;28:2555\u201362.","journal-title":"Nat Med"},{"key":"4043_CR9","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1001\/jama.2020.12134","volume":"324","author":"S Palmqvist","year":"2020","unstructured":"Palmqvist S, Janelidze S, Quiroz YT, Zetterberg H, Lopera F, Stomrud E, et al. Discriminative accuracy of plasma phospho-tau217 for alzheimer disease vs other neurodegenerative disorders. JAMA. 2020;324:772\u201381.","journal-title":"JAMA"},{"key":"4043_CR10","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.1038\/s41591-022-01822-2","volume":"28","author":"MM Mielke","year":"2022","unstructured":"Mielke MM, Dage JL, Frank RD, Algeciras-Schimnich A, Knopman DS, Lowe VJ, et al. Performance of plasma phosphorylated tau 181 and 217 in the community. Nat Med. 2022;28:1398\u2013405.","journal-title":"Nat Med"},{"key":"4043_CR11","first-page":"1797","volume":"28","author":"M Mil\u00e0-Alom\u00e0","year":"2022","unstructured":"Mil\u00e0-Alom\u00e0 M, Ashton NJ, Shekari M, Salvad\u00f3 G, Ortiz-Romero P, Montoliu-Gaya L, et al. Plasma p-tau231 and p-tau217 as state markers of amyloid-\u03b2 pathology in preclinical Alzheimer\u2019s disease. Nat Med. 2022;28:1797\u2013801.","journal-title":"Nat Med"},{"key":"4043_CR12","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/S1474-4422(21)00214-3","volume":"20","author":"EH Thijssen","year":"2021","unstructured":"Thijssen EH, La Joie R, Strom A, Fonseca C, Iaccarino L, Wolf A, et al. Plasma phosphorylated tau 217 and phosphorylated tau 181 as biomarkers in Alzheimer\u2019s disease and frontotemporal lobar degeneration: a retrospective diagnostic performance study. Lancet Neurol. 2021;20:739\u201352.","journal-title":"Lancet Neurol"},{"key":"4043_CR13","doi-asserted-by":"publisher","DOI":"10.1002\/alz.70535","volume":"21","author":"S Palmqvist","year":"2025","unstructured":"Palmqvist S, Whitson HE, Allen LA, Suarez-Calvet M, Galasko D, Karikari TK, et al. Alzheimer\u2019s Association Clinical Practice Guideline on the use of blood-based biomarkers in the diagnostic workup of suspected Alzheimer\u2019s disease within specialized care settings. Alzheimers Dement. 2025;21:e70535.","journal-title":"Alzheimers Dement"},{"key":"4043_CR14","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1001\/jamaneurol.2024.5017","volume":"82","author":"L VandeVrede","year":"2025","unstructured":"VandeVrede L, Cho H, Sanderson-Cimino M, Wekselman F, Cobigo Y, Gorno-Tempini ML, et al. Detection of alzheimer neuropathology in alzheimer and non-alzheimer clinical syndromes with blood-based biomarkers. JAMA Neurol. 2025;82:344\u201354.","journal-title":"JAMA Neurol"},{"key":"4043_CR15","doi-asserted-by":"publisher","first-page":"3234","DOI":"10.1093\/brain\/awaa286","volume":"143","author":"N Mattsson-Carlgren","year":"2020","unstructured":"Mattsson-Carlgren N, Janelidze S, Palmqvist S, Cullen N, Svenningsson AL, Strandberg O, et al. Longitudinal plasma p-tau217 is increased in early stages of Alzheimer\u2019s disease. Brain. 2020;143:3234\u201341.","journal-title":"Brain"},{"key":"4043_CR16","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1001\/jama.2024.13855","volume":"332","author":"S Palmqvist","year":"2024","unstructured":"Palmqvist S, Tideman P, Mattsson-Carlgren N, Schindler SE, Smith R, Ossenkoppele R, et al. Blood biomarkers to detect alzheimer disease in primary care and secondary care. JAMA. 2024;332:1245\u201357.","journal-title":"JAMA"},{"key":"4043_CR17","doi-asserted-by":"publisher","first-page":"2027","DOI":"10.1038\/s41591-025-03605-x","volume":"31","author":"G Grande","year":"2025","unstructured":"Grande G, Valletta M, Rizzuto D, Xia X, Qiu C, Orsini N, et al. Blood-based biomarkers of Alzheimer\u2019s disease and incident dementia in the community. Nat Med. 2025;31:2027\u201335.","journal-title":"Nat Med"},{"key":"4043_CR18","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1093\/brain\/awae368","volume":"148","author":"A Pilotto","year":"2025","unstructured":"Pilotto A, Quaresima V, Trasciatti C, Tolassi C, Bertoli D, Mordenti C, et al. Plasma p-tau217 in Alzheimer\u2019s disease: Lumipulse and ALZpath SIMOA head-to-head comparison. Brain. 2025;148:408\u201315.","journal-title":"Brain"},{"key":"4043_CR19","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1001\/jamaneurol.2023.5319","volume":"81","author":"NJ Ashton","year":"2024","unstructured":"Ashton NJ, Brum WS, Molfetta GD, Benedet AL, Arslan B, Jonaitis E, et al. Diagnostic accuracy of a plasma phosphorylated tau 217 immunoassay for alzheimer disease pathology. JAMA Neurol. 2024;81:255.","journal-title":"JAMA Neurol"},{"key":"4043_CR20","doi-asserted-by":"publisher","DOI":"10.1002\/alz.14397","volume":"21","author":"CE Teunissen","year":"2025","unstructured":"Teunissen CE, Kolster R, Triana-Baltzer G, Janelidze S, Zetterberg H, Kolb HC. Plasma p-tau immunoassays in clinical research for Alzheimer\u2019s disease. Alzheimers Dement. 2025;21:e14397.","journal-title":"Alzheimers Dement"},{"key":"4043_CR21","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1093\/brain\/awae346","volume":"148","author":"N Warmenhoven","year":"2025","unstructured":"Warmenhoven N, Salvad\u00f3 G, Janelidze S, Mattsson-Carlgren N, Bali D, Dolado AO, et al. A comprehensive head-to-head comparison of key plasma phosphorylated tau 217 biomarker tests. Brain. 2025;148:416\u201331.","journal-title":"Brain"},{"key":"4043_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2024.105046","volume":"102","author":"J Therriault","year":"2024","unstructured":"Therriault J, Ashton NJ, Pola I, Triana-Baltzer G, Brum WS, Molfetta GD, et al. Comparison of two plasma p-tau217 assays to detect and monitor Alzheimer\u2019s pathology. EBioMedicine. 2024;102:105046.","journal-title":"EBioMedicine"},{"key":"4043_CR23","doi-asserted-by":"publisher","first-page":"1592","DOI":"10.1093\/brain\/awac333","volume":"146","author":"S Janelidze","year":"2023","unstructured":"Janelidze S, Bali D, Ashton NJ, Barth\u00e9lemy NR, Vanbrabant J, Stoops E, et al. Head-to-head comparison of 10 plasma phospho-tau assays in prodromal Alzheimer\u2019s disease. Brain. 2023;146:1592\u2013601.","journal-title":"Brain"},{"key":"4043_CR24","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1192\/bjp.140.6.566","volume":"140","author":"CP Hughes","year":"1982","unstructured":"Hughes CP, Berg L, Danziger W, Coben LA, Martin RL. A new clinical scale for the staging of dementia. Br J Psychiatry. 1982;140:566\u201372.","journal-title":"Br J Psychiatry"},{"key":"4043_CR25","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.jalz.2011.03.005","volume":"7","author":"GM McKhann","year":"2011","unstructured":"McKhann GM, Knopman DS, Chertkow H, Hyman BT, Jack CR, Kawas CH, et al. The diagnosis of dementia due to alzheimer\u2019s disease: recommendations from the national institute on aging-alzheimer\u2019s association workgroups on diagnostic guidelines for alzheimer\u2019s disease. Alzheimers Dement. 2011;7:263\u20139.","journal-title":"Alzheimers Dement"},{"key":"4043_CR26","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.jalz.2011.03.008","volume":"7","author":"MS Albert","year":"2011","unstructured":"Albert MS, DeKosky ST, Dickson D, Dubois B, Feldman HH, Fox NC, et al. The diagnosis of mild cognitive impairment due to alzheimer\u2019s disease: recommendations from the national institute on aging-alzheimer\u2019s association workgroups on diagnostic guidelines for alzheimer\u2019s disease. Alzheimers Dement. 2011;7:270\u20139.","journal-title":"Alzheimers Dement"},{"key":"4043_CR27","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1016\/S1474-4422(14)70090-0","volume":"13","author":"B Dubois","year":"2014","unstructured":"Dubois B, Feldman HH, Jacova C, Hampel H, Molinuevo JL, Blennow K, et al. Advancing research diagnostic criteria for Alzheimer\u2019s disease: the IWG-2 criteria. Lancet Neurol. 2014;13:614\u201329.","journal-title":"Lancet Neurol"},{"key":"4043_CR28","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1097\/WAD.0000000000000034","volume":"28","author":"P Sachdev","year":"2014","unstructured":"Sachdev P, Kalaria R, O\u2019Brien J, Skoog I, Alladi S, Black SE, et al. Diagnostic criteria for vascular cognitive disorders: a VASCOG statement. Alzheimer Dis Assoc Disord. 2014;28:206\u201318.","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"4043_CR29","doi-asserted-by":"publisher","first-page":"2456","DOI":"10.1093\/brain\/awr179","volume":"134","author":"K Rascovsky","year":"2011","unstructured":"Rascovsky K, Hodges JR, Knopman D, Mendez MF, Kramer JH, Neuhaus J, et al. Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia. Brain. 2011;134:2456\u201377.","journal-title":"Brain"},{"key":"4043_CR30","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1212\/WNL.0b013e31821103e6","volume":"76","author":"ML Gorno-Tempini","year":"2011","unstructured":"Gorno-Tempini ML, Hillis AE, Weintraub S, Kertesz A, Mendez M, Cappa SF, et al. Classification of primary progressive aphasia and its variants. Neurology. 2011;76:1006\u201314.","journal-title":"Neurology"},{"key":"4043_CR31","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-83919-x","volume":"15","author":"Y Liu","year":"2025","unstructured":"Liu Y, Liu X, Che P, Wang Y, Piao Z, Wang Y, et al. A cytometric bead array for the measurement of plasma biomarker levels in patients with Alzheimer\u2019s disease. Sci Rep. 2025;15:9767.","journal-title":"Sci Rep"},{"key":"4043_CR32","doi-asserted-by":"publisher","first-page":"3015","DOI":"10.1039\/D2LC00388K","volume":"22","author":"S-M Yang","year":"2022","unstructured":"Yang S-M, Bi Q, Zhang WJ, Cui X, Zhou Y, Yuan C, et al. Highly accurate multiprotein detection on a digital ELISA platform. Lab Chip. 2022;22:3015\u201324.","journal-title":"Lab Chip"},{"key":"4043_CR33","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2024.1445479","volume":"15","author":"W Yang","year":"2024","unstructured":"Yang W, Guan F, Yang L, Shou G, Zhu F, Xu Y, et al. Highly sensitive blood-based biomarkers detection of beta-amyloid and phosphorylated-tau181 for Alzheimer\u2019s disease. Front Neurol. 2024;15:1445479.","journal-title":"Front Neurol"},{"key":"4043_CR34","doi-asserted-by":"publisher","first-page":"6183","DOI":"10.1002\/alz.14100","volume":"20","author":"L Du","year":"2024","unstructured":"Du L, Langhough RE, Wilson RE, Reyes RER, Hermann BP, Jonaitis EM, et al. Longitudinal plasma phosphorylated-tau217 and other related biomarkers in a non-demented alzheimer\u2019s risk-enhanced sample. Alzheimers Dement. 2024;20:6183\u2013204.","journal-title":"Alzheimers Dement"},{"key":"4043_CR35","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1001\/jamaneurol.2021.2293","volume":"78","author":"MM Mielke","year":"2021","unstructured":"Mielke MM, Frank RD, Dage JL, Jeromin A, Ashton NJ, Blennow K, et al. Comparison of plasma phosphorylated tau species with amyloid and tau positron emission tomography, neurodegeneration, vascular pathology, and cognitive outcomes. JAMA Neurol. 2021;78:1108\u201317.","journal-title":"JAMA Neurol"},{"key":"4043_CR36","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000213438","volume":"104","author":"E Sanchez","year":"2025","unstructured":"Sanchez E, Coughlan GT, Wilkinson T, Ramirez J, Mirza SS, Baril A-A, et al. Association of plasma biomarkers with longitudinal atrophy and microvascular burden on mri across neurodegenerative and cerebrovascular diseases. Neurology. 2025;104:e213438.","journal-title":"Neurology"},{"key":"4043_CR37","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1186\/s13195-024-01630-5","volume":"16","author":"AL Wojda\u0142a","year":"2024","unstructured":"Wojda\u0142a AL, Vanbrabant J, Bayoumy S, Antwi-Berko D, Bastard NL, van der Flier WM, et al. Analytical and clinical performance of eight Simoa\u00ae and Lumipulse\u00ae assays for automated measurement of plasma p-tau181 and p-tau217. Alzheimers Res Ther. 2024;16:266.","journal-title":"Alzheimers Res Ther"},{"key":"4043_CR38","doi-asserted-by":"publisher","first-page":"6506","DOI":"10.1002\/alz.14140","volume":"20","author":"DJ Figdore","year":"2024","unstructured":"Figdore DJ, Griswold M, Bornhorst JA, Graff-Radford J, Ramanan VK, Vemuri P, et al. Optimizing cutpoints for clinical interpretation of brain amyloid status using plasma p-tau217 immunoassays. Alzheimers Dement. 2024;20:6506\u201316.","journal-title":"Alzheimers Dement"}],"container-title":["Translational Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41398-026-04043-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41398-026-04043-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41398-026-04043-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T09:19:22Z","timestamp":1780391962000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41398-026-04043-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,21]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4043"],"URL":"https:\/\/doi.org\/10.1038\/s41398-026-04043-0","relation":{},"ISSN":["2158-3188"],"issn-type":[{"value":"2158-3188","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,21]]},"assertion":[{"value":"3 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 March 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 April 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was conducted in accordance with the Declaration of Helsinki and approved by the Ethics Committee of Tianjin Medical University General Hospital. Written informed consent was obtained from all participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}],"article-number":"293"}}